- Home
- IOVA vs ARCH Comparison
IOVA vs ARCH Comparison
Compare IOVA & ARCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- ARCH
- Stock Information
- Founded
- IOVA 2007
- ARCH 1969
- Country
- IOVA United States
- ARCH United States
- Employees
- IOVA N/A
- ARCH N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- ARCH Coal Mining
- Sector
- IOVA Health Care
- ARCH Energy
- Exchange
- IOVA Nasdaq
- ARCH Nasdaq
- Market Cap
- IOVA 3.0B
- ARCH 2.6B
- IPO Year
- IOVA N/A
- ARCH 1988
- Fundamental
- Price
- IOVA $8.18
- ARCH $164.06
- Analyst Decision
- IOVA Strong Buy
- ARCH Buy
- Analyst Count
- IOVA 9
- ARCH 5
- Target Price
- IOVA $23.33
- ARCH $173.60
- AVG Volume (30 Days)
- IOVA 7.2M
- ARCH 378.5K
- Earning Date
- IOVA 11-07-2024
- ARCH 11-05-2024
- Dividend Yield
- IOVA N/A
- ARCH 0.83%
- EPS Growth
- IOVA N/A
- ARCH N/A
- EPS
- IOVA N/A
- ARCH 9.67
- Revenue
- IOVA $90,858,000.00
- ARCH $2,645,357,000.00
- Revenue This Year
- IOVA $13,827.67
- ARCH N/A
- Revenue Next Year
- IOVA $183.70
- ARCH N/A
- P/E Ratio
- IOVA N/A
- ARCH $16.96
- Revenue Growth
- IOVA 12751.20
- ARCH N/A
- 52 Week Low
- IOVA $4.44
- ARCH $116.44
- 52 Week High
- IOVA $18.33
- ARCH $187.60
- Technical
- Relative Strength Index (RSI)
- IOVA 32.59
- ARCH 67.09
- Support Level
- IOVA $9.31
- ARCH $161.08
- Resistance Level
- IOVA $10.86
- ARCH $171.87
- Average True Range (ATR)
- IOVA 0.71
- ARCH 5.51
- MACD
- IOVA -0.37
- ARCH 0.95
- Stochastic Oscillator
- IOVA 1.48
- ARCH 77.43
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About ARCH Arch Resources Inc.
Arch Resources Inc is a producer of metallurgical and coking coal. The company sells its coal to power plants, steel mills, and industrial facilities. Its operating segment includes Metallurgical (MET) and Thermal. It generates maximum revenue from the Metallurgical (MET) segment. Geographically, it derives a majority of its revenue from Asia.